Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial

Blinman, P.; Mileshkin, L.; Khaw, P.; Goss, G.; Johnson, C.; Capp, A.; ... ; PORTEC Grp (2016)

Article / Letter to editor

• endometrial cancer
• clinician preferences
• adjuvant chemotherapy
• decision-making
• patient preferences
• outcomes research

• All authors: Blinman, P.; Mileshkin, L.; Khaw, P.; Goss, G.; Johnson, C.; Capp, A.; Brooks, S.; Wain, G.; Kolodziej, I.; Veillard, A.S.; O'Connell, R.; Creutzberg, C.L.; Stockler, M.R.; ANZGOG; PORTEC Grp
• Date: 2016-11-08
• Journal: British Journal of Cancer
• Volume: 115
• Issue: 10
• Pages: 1179 - 1185
• DOI: doi:10.1038/bjc.2016.323